392 related articles for article (PubMed ID: 16766544)
1. Positive effect of dietary soy in ESRD patients with systemic inflammation--correlation between blood levels of the soy isoflavones and the acute-phase reactants.
Fanti P; Asmis R; Stephenson TJ; Sawaya BP; Franke AA
Nephrol Dial Transplant; 2006 Aug; 21(8):2239-46. PubMed ID: 16766544
[TBL] [Abstract][Full Text] [Related]
2. Effects of high- and low-isoflavone (phytoestrogen) soy foods on inflammatory biomarkers and proinflammatory cytokines in middle-aged men and women.
Jenkins DJ; Kendall CW; Connelly PW; Jackson CJ; Parker T; Faulkner D; Vidgen E
Metabolism; 2002 Jul; 51(7):919-24. PubMed ID: 12077742
[TBL] [Abstract][Full Text] [Related]
3. Serum isoflavones and soya food intake in Japanese, Thai and American end-stage renal disease patients on chronic haemodialysis.
Fanti P; Stephenson TJ; Kaariainen IM; Rezkalla B; Tsukamoto Y; Morishita T; Nomura M; Kitiyakara C; Custer LJ; Franke AA
Nephrol Dial Transplant; 2003 Sep; 18(9):1862-8. PubMed ID: 12937236
[TBL] [Abstract][Full Text] [Related]
4. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
Panichi V; Taccola D; Rizza GM; Consani C; Migliori M; Filippi C; Paoletti S; Sidoti A; Borracelli D; Panicucci E; Giovannini L
J Nephrol; 2004; 17(5):715-20. PubMed ID: 15593040
[TBL] [Abstract][Full Text] [Related]
5. Effect of a soy isoflavone supplement on lung function and clinical outcomes in patients with poorly controlled asthma: a randomized clinical trial.
Smith LJ; Kalhan R; Wise RA; Sugar EA; Lima JJ; Irvin CG; Dozor AJ; Holbrook JT;
JAMA; 2015 May; 313(20):2033-43. PubMed ID: 26010632
[TBL] [Abstract][Full Text] [Related]
6. Significance of albumin and C-reactive protein variations in 300 end stage renal disease patients in Tehran University of Medical Sciences Hospitals during year 2010.
Dashti N; Einollahi N; Nabatchian F; Moradi Sarabi M; Zarebavani M
Acta Med Iran; 2012; 50(3):197-202. PubMed ID: 22418989
[TBL] [Abstract][Full Text] [Related]
7. Nutritional status and overhydration: can bioimpedance spectroscopy be useful in haemodialysis patients?
Garagarza C; João-Matias P; Sousa-Guerreiro C; Amaral T; Aires I; Ferreira C; Jorge C; Gil C; Ferreira A
Nefrologia; 2013; 33(5):667-74. PubMed ID: 24089158
[TBL] [Abstract][Full Text] [Related]
8. Effect of soy isoflavones on circulating C-reactive protein in postmenopausal women: meta-analysis of randomized controlled trials.
Dong JY; Wang P; He K; Qin LQ
Menopause; 2011 Nov; 18(11):1256-62. PubMed ID: 21712733
[TBL] [Abstract][Full Text] [Related]
9. Association of depression with markers of nutrition and inflammation in chronic kidney disease and end-stage renal disease.
Kalender B; Ozdemir AC; Koroglu G
Nephron Clin Pract; 2006; 102(3-4):c115-21. PubMed ID: 16282695
[TBL] [Abstract][Full Text] [Related]
10. Soy isoflavones in the treatment of prostate cancer.
Hussain M; Banerjee M; Sarkar FH; Djuric Z; Pollak MN; Doerge D; Fontana J; Chinni S; Davis J; Forman J; Wood DP; Kucuk O
Nutr Cancer; 2003; 47(2):111-7. PubMed ID: 15087261
[TBL] [Abstract][Full Text] [Related]
11. Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women.
Weickert MO; Reimann M; Otto B; Hall WL; Vafeiadou K; Hallund J; Ferrari M; Talbot D; Branca F; Bügel S; Williams CM; Zunft HJ; Koebnick C
J Negat Results Biomed; 2006 Aug; 5():11. PubMed ID: 16907966
[TBL] [Abstract][Full Text] [Related]
12. Are metalloproteins and acute phase reactants associated with cardiovascular disease in end-stage renal failure?
Healy H; Reith D; Morgan C; Clague A; Westhuyzen J
Ann Clin Lab Sci; 2000 Jul; 30(3):295-304. PubMed ID: 10945571
[TBL] [Abstract][Full Text] [Related]
13. Effects of unsaturated fat dietary supplements on blood lipids, and on markers of malnutrition and inflammation in hemodialysis patients.
Ewers B; Riserus U; Marckmann P
J Ren Nutr; 2009 Sep; 19(5):401-11. PubMed ID: 19541503
[TBL] [Abstract][Full Text] [Related]
14. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities.
Fialová L; Kalousová M; Soukupová J; Sulková S; Merta M; Jelínková E; Horejsí M; Srámek P; Malbohan I; Mikulíková L; Tesar V; Zima T
Kidney Blood Press Res; 2004; 27(2):88-95. PubMed ID: 14739577
[TBL] [Abstract][Full Text] [Related]
15. Additive effects of isoflavones and exercise training on inflammatory cytokines and body composition in overweight and obese postmenopausal women: a randomized controlled trial.
Lebon J; Riesco E; Tessier D; Dionne IJ
Menopause; 2014 Aug; 21(8):869-75. PubMed ID: 24378766
[TBL] [Abstract][Full Text] [Related]
16. The hypoglycemic effects of soy isoflavones on postmenopausal women.
Cheng SY; Shaw NS; Tsai KS; Chen CY
J Womens Health (Larchmt); 2004 Dec; 13(10):1080-6. PubMed ID: 15650341
[TBL] [Abstract][Full Text] [Related]
17. Type 2 diabetes in patients with end-stage renal disease is not associated with further increased serum inflammatory parameters.
Bodlaj G; Berg J; Pichler R; Sailer T; Biesenbach G
J Nephrol; 2004; 17(1):112-7. PubMed ID: 15151267
[TBL] [Abstract][Full Text] [Related]
18. Effects of isoflavone supplements vs. soy foods on blood concentrations of genistein and daidzein in adults.
Gardner CD; Chatterjee LM; Franke AA
J Nutr Biochem; 2009 Mar; 20(3):227-34. PubMed ID: 18602820
[TBL] [Abstract][Full Text] [Related]
19. The Effects of Soy Isoflavones on Metabolic Status of Patients With Polycystic Ovary Syndrome.
Jamilian M; Asemi Z
J Clin Endocrinol Metab; 2016 Sep; 101(9):3386-94. PubMed ID: 27490918
[TBL] [Abstract][Full Text] [Related]
20. Distribution of isoflavones in samples of serum, liver and mammary glands of rats or pigs fed dietary isoflavones.
Gilani GS; Farmer C; Dyck M; Robertson P; Dahiya J; Sepehr E; Fan L; Nicolidakis H; Curran I; Cooke GM
Ann Nutr Metab; 2011; 58(3):171-80. PubMed ID: 21654164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
